UMC Utrecht Holding BV engages in utilization and commercialization of academic researches. It offers research support and training services. The company was founded in 1996 and is headquartered in Utrecht, the Netherlands.

Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.

Guangzhou Daidai Pharmaceutical Technology Co., Ltd., established on 2013-05-20, Business scope includes medical research and experimental development;drug development;Retailing of cosmetics and hygiene products;Wholesale of cosmetics and hygiene products;Nutrition and Health Consulting Services;Health Sciences Program Research,to develop;Acupuncture Medicine Research;Manufacturing of dental equipment and appliances;

MedEXGen, Inc. is a South Korean private company located in Seoul that designs and develops protein therapeutics. It was founded by Yong Hoon Chung.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Jilin Dali Technology Co., Ltd., established on 2020-08-28, Business scope includes engineering and technology research and experimental development;R&D and application of cell technology;Technology intermediary service;business management;translation service;Information Consulting Service(Not including licensing information consulting services);Business Management Consulting;Engage in investment activities with own funds;Health Consulting Services(Does not include medical services);Advertising Design,acting;advertisement making;Camera and Video Production Services;Graphic design and production;Corporate Image Planning;Professional Design Services;Conference and Exhibition Services;building cleaning service;Ticket agency service;Special Equipment Repair;Information system integration service;property management;road freight transport(Does not contain dangerous goods);Various construction activities;advertising(radio station,television station,Newspaper Publishing Unit);Organization and planning of cultural and artistic exchange activities;software development;data processing;Educational information consultation(No coaching training);Enterprise Marketing Planning;Import and export,Technology Import and Export;Organize cultural and artistic exchange activities(without show);electronic product,communication equipment(Does not include radio transmitters),Computer hardware and software,Equipment,Chemical Products(Free of Hazardous Chemicals),sporting goods,knitted goods,clothing,books,Newspaper,periodicals,daily necessities,Jewelry,fruit,vegetable,crafts(Does not contain cultural relics),Toy,flowers,Pre-packaged food,electronic publication,Sales of audio-visual products and sales via the Internet(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Astellas US LLC, part of Astellas Pharma, Inc., is an American company located in Northbrook, IL. The firm manufactures and markets pharmaceutical products. Kenji Yasukawa is the current CEO of the firm.

Leiden University Medical Center (Dutch: Leids Universitair Medisch Centrum) or LUMC is the university hospital affiliated with Leiden University, of which it forms the medical faculty. It is located in Leiden, Netherlands. LUMC is a modern university medical center for research, education and patient care. Its research practice ranges from pure fundamental medical research to applied clinical research.

Fuzhou Maixin Biotech Co., Ltd. (doing business as MXB Biotechnologies), part of Beijing Strong Biotechnologies, Inc., is a Chinese company located in Fuzhou. The firm engages in production, research & development and sales and focus on tissue-based diagnostics specifically IHC antibodies, reagents and the automation of IHC and ISH. It was founded in 1993. Xiao Ya Wang is the current CEO of the firm. Fuzhou Maixin Biotech Co. Ltd. acquired Fuzhou Maixin Biotech Co., Ltd. on September 30, 2020 for $255.21 million.

Showa Pharmaceutical University (昭和薬科大学, Shōwa yakka daigaku) is a private university at Machida, Tokyo, Japan. The predecessor, Showa Women's Pharmaceutical Junior College, was founded in 1930, and it was chartered as a university in 1949.

Sumitomo Electric Industries, Ltd. engages in the manufacture and sale of electrical wires, cables, and other communication wiring products. It operates through the following business segments: Automotive, Infocommunications, Electronics, Environment and Energy, and Industrial Materials and Others. The Automotive segment supplies wiring harnesses, anti-vibration rubber products, and other automotive parts. The Infocommunications segment offers optical fiber cables, optical fiber fusion splicers, optical data links and other optical components, and access network system products. The Electronics segment provides electronic wires, compound semiconductors, materials for electronic components, and irradiated products. The Environment and Energy segment includes copper wire rods, electric power cables, magnet wires, power systems, and supervisory telecontrol equipment. The Industrial Materials and Others segment consists of special steel wires, cutting tools, diamond and cubic boron nitride tools, and sintered parts. The company was founded in April 1897 and is headquartered in Osaka, Japan.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.